NEW YORK (GenomeWeb News) - Leiden University Medical Center said yesterday that it has acquired a FlexArrayer from FlexGen for in-house synthesis of oligonucleotide microarrays.
 
FlexGen is a LUMC spinoff company.
 
Johan den Dunnen, head of the Leiden Genome Technology Center, said in a statement that the center will use the FlexArrayer for “well established types of genetic analyses but [we] also intend to work on the development of new applications.”
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.